{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:24:00Z","timestamp":1761294240771},"reference-count":53,"publisher":"Oceanside Publications Inc.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["allergy asthma proc"],"published-print":{"date-parts":[[2021,1,1]]},"abstract":"<jats:p>Immediate hypersensitivity to drugs is characterized by symptoms such as hives, swelling, and wheezing. To prevent a negative impact on care, assessment by an allergist is important. Evaluation requires a clear clinical history, but it is often lacking or vague, which makes a diagnosis difficult. Allergists instead can use skin testing and drug challenge to evaluate drug hypersensitivity reactions, which help the patient and provider understand the causative drug(s) and, more importantly, enables the use of the exonerated drug(s). Although penicillin skin testing is standardized, well described, and widely used, skin testing for most other drugs requires the use of a nonirritating skin testing concentration that can have a low negative predictive value. Drug challenges are the criterion standard for confirming tolerance. The allergist must obtain an in-depth clinical history and then follow with skin testing and\/or drug challenges when indicated to determine which drugs can be de-labelled and which should be avoided. In this review, we focused on the evaluation of drug hypersensitivity reactions to antibiotics, perioperative agents, biologics, and chemotherapeutics.<\/jats:p>","DOI":"10.2500\/aap.2021.42.200091","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T14:00:25Z","timestamp":1609941625000},"page":"16-21","source":"Crossref","is-referenced-by-count":9,"title":["Skin testing and drug challenge in the evaluation of drug hypersensitivity reactions"],"prefix":"10.2500","volume":"42","author":[{"given":"Anna R.","family":"Wolfson","sequence":"first","affiliation":[{"name":"From the Harvard Medical School, Boston, Massachusetts; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleena","family":"Banerji","sequence":"additional","affiliation":[{"name":"From the Harvard Medical School, Boston, Massachusetts; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1355","reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.anai.2010.08.002","article-title":"Drug allergy: an updated practice parameter","volume":"105","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jaip.2017.05.005","article-title":"The role of the clinical history in drug allergy prediction","volume":"6","author":"Blumenthal","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0091-6749(03)01783-4","article-title":"Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics","volume":"112","author":"Empedrad","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"B4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jaci.2011.10.010","article-title":"A protocol for risk stratification of patients with carboplatin-induced hypersensitivity reactions","volume":"129","author":"Patil","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0091-6749(97)70222-7","article-title":"Timing of venom skin tests and IgE determinations after insect sting anaphylaxis","volume":"100","author":"Goldberg","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"B6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2222.2007.02867.x","article-title":"Oral challenges are needed in the diagnosis of beta-lactam hypersensitivity","volume":"38","author":"Bousquet","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"B7","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jaip.2014.08.001","article-title":"Safety and outcomes of test doses for the evaluation of adverse drug reactions: a 5-year retrospective review","volume":"2","author":"Iammatteo","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(18)32218-9","article-title":"Antibiotic allergy","volume":"393","author":"Blumenthal","year":"2019","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1034\/j.1398-9995.2003.00279.x","article-title":"Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations","volume":"58","author":"Aberer","year":"2003","journal-title":"Allergy"},{"key":"B10","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jaip.2016.09.041","article-title":"Identifying allergic drug reactions through placebo-controlled graded challenges","volume":"5","author":"Iammatteo","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B11","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/archinte.1992.00400170105020","article-title":"Results of the National Institute of Allergy and Infectious Diseases Collaborative clinical trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults","volume":"152","author":"Sogn","year":"1992","journal-title":"Arch Intern Med"},{"issue":"3","key":"B12","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.anai.2017.06.009","article-title":"Utility of minor determinants for skin testing in inpatient penicillin allergy evaluation","volume":"119","author":"Geng","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaip.2013.02.002","article-title":"Safely diagnosing clinically significant penicillin allergy using only penicilloyl-poly-lysine, penicillin, and oral amoxicillin","volume":"1","author":"Macy","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B14","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jaip.2017.08.006","article-title":"The cost of penicillin allergy evaluation","volume":"6","author":"Blumenthal","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B15","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jaip.2013.01.006","article-title":"Treatment of patients with a history of penicillin allergy in a large tertiary-care academic hospital","volume":"1","author":"Picard","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B16","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jaci.2015.10.026","article-title":"Consequences of avoiding \u03b2-lactams in patients with \u03b2-lactam allergies","volume":"137","author":"Jeffres","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B17","doi-asserted-by":"crossref","first-page":"154","DOI":"10.37765\/ajmc.2020.42832","article-title":"High-cost, high-need patients: the impact of reported penicillin allergy","volume":"26","author":"Blumenthal","year":"2020","journal-title":"Am J Manag Care"},{"key":"B18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/cid\/cix794","article-title":"The impact of a reported penicillin allergy on surgical site infection risk","volume":"66","author":"Blumenthal","year":"2018","journal-title":"Clin Infect Dis"},{"key":"B19","doi-asserted-by":"crossref","first-page":"k2400","DOI":"10.1136\/bmj.k2400","article-title":"Risk of meticillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study","volume":"361","author":"Blumenthal","year":"2018","journal-title":"BMJ"},{"key":"B20","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaci.2013.09.021","article-title":"Health care use and serious infection prevalence associated with penicillin \u201callergy\u201d in hospitalized patients: a cohort study","volume":"133","author":"Macy","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B21","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jaip.2017.02.019","article-title":"Addressing inpatient beta-lactam allergies: a multihospital implementation","volume":"5","author":"Blumenthal","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jaci.2017.02.005","article-title":"Tackling inpatient penicillin allergies: assessing tools for antimicrobial stewardship","volume":"140","author":"Blumenthal","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B23","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S1081-1206(10)61100-3","article-title":"Safety and effectiveness of a preoperative allergy clinic in decreasing vancomycin use in patients with a history of penicillin allergy","volume":"97","author":"Park","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B24","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.jaip.2019.04.006","article-title":"Risk-based pathway for outpatient penicillin allergy evaluations","volume":"7","author":"Blumenthal","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B25","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.anai.2015.05.011","article-title":"Impact of a clinical guideline for prescribing antibiotics to inpatients reporting penicillin or cephalosporin allergy","volume":"115","author":"Blumenthal","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B26","doi-asserted-by":"crossref","first-page":"266","DOI":"10.7326\/0003-4819-146-4-200702200-00005","article-title":"Brief communication: tolerability of meropenem in patients with IgE-mediated hypersensitivity to penicillins","volume":"146","author":"Romano","year":"2007","journal-title":"Ann Intern Med"},{"key":"B27","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1056\/NEJMc053529","article-title":"Imipenem in patients with immediate hypersensitivity to penicillins","volume":"354","author":"Romano","year":"2006","journal-title":"N Engl J Med"},{"key":"B28","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1016\/j.jaip.2019.05.038","article-title":"Cross-reactivity to cephalosporins and carbapenems in penicillin-allergic patients: two systematic reviews and meta-analyses","volume":"7","author":"Picard","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B29","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jaip.2017.08.027","article-title":"Cross-reactivity in \u03b2-lactam allergy","volume":"6","author":"Zagursky","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B30","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/j.diagmicrobio.2006.12.004","article-title":"Use of selected cephalosporins in penicillin-allergic patients: a paradigm shift","volume":"57","author":"Pichichero","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"B31","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1331\/JAPhA.2008.07006","article-title":"Cephalosporin use in treatment of patients with penicillin allergies","volume":"48","author":"DePestel","year":"2008","journal-title":"J Am Pharm Assoc (2003)"},{"key":"B32","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bja.2018.04.015","article-title":"Anaesthesia, surgery, and life-threatening allergic reactions: management and outcomes in the 6th National Audit Project (NAP6)","volume":"121","author":"Harper","year":"2018","journal-title":"Br J Anaesth"},{"key":"B33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaip.2014.11.005","article-title":"Antibiotics are an important identifiable cause of perioperative anaphylaxis in the United States","volume":"3","author":"Gonzalez-Estrada","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B34","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1213\/ANE.0b013e31822d45ac","article-title":"Allergic reactions during anesthesia at a large United States referral center","volume":"113","author":"Gurrieri","year":"2011","journal-title":"Anesth Analg"},{"key":"B35","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jaip.2014.11.011","article-title":"Comprehensive allergy evaluation is useful in the subsequent care of patients with drug hypersensitivity reactions during anesthesia","volume":"3","author":"Guyer","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B36","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1111\/all.13820","article-title":"An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactions","volume":"74","author":"Garvey","year":"2019","journal-title":"Allergy"},{"key":"B37","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jaip.2016.02.008","article-title":"Antibiotics are the most commonly identified cause of perioperative hypersensitivity reactions","volume":"4","author":"Kuhlen","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s40521-020-00242-2","article-title":"Hypersensitivity reactions to biologicals: from bench to bedside","volume":"7","author":"Akarsu","year":"2020","journal-title":"Curr Treat Options Allergy"},{"key":"B39","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/all.12350","article-title":"International consensus on drug allergy","volume":"69","author":"Demoly","year":"2014","journal-title":"Allergy"},{"key":"B40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13223-020-00448-8","article-title":"Type I allergic reaction to rituximab upon first lifetime exposure: a case report","volume":"16","author":"Polito","year":"2020","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jaip.2016.06.022","article-title":"Reactions to rituximab in an outpatient infusion center: a 5-year review","volume":"5","author":"Levin","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B42","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJMoa074943","article-title":"Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose","volume":"358","author":"Chung","year":"2008","journal-title":"N Engl J Med"},{"key":"B43","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.anai.2011.03.014","article-title":"Adalimumab desensitization after anaphylactic reaction","volume":"106","author":"Quercia","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B44","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/pai.13114","article-title":"Severe hypersensitivity reactions to biological drugs in children with rheumatic diseases","volume":"30","author":"Soyer","year":"2019","journal-title":"Pediatr Allergy Immunol"},{"key":"B45","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jaip.2016.12.001","article-title":"Current knowledge and management of hypersensitivity reactions to monoclonal antibodies","volume":"5","author":"Picard","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B46","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40425-018-0343-9","article-title":"Cytokine release syndrome","volume":"6","author":"Shimabukuro-Vornhagen","year":"2018","journal-title":"J Immunother Cancer"},{"key":"B47","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jaci.2009.09.009","article-title":"Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment","volume":"124","author":"Brennan","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"B48","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jaci.2008.02.044","article-title":"Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases","volume":"122","author":"Castells","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"B49","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jaip.2019.08.055","article-title":"Platin risk stratification algorithm with modified intradermal skin test protocol","volume":"8","author":"Levin","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B50","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jaip.2015.07.003","article-title":"Skin testing in the evaluation and management of carboplatin-related hypersensitivity reactions","volume":"3","author":"Lax","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B51","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.jaci.2015.10.039","article-title":"Risk stratification and skin testing to guide re-exposure in taxane-induced hypersensitivity reactions","volume":"137","author":"Picard","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B52","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.jaip.2017.08.025","article-title":"Utility of risk stratification for paclitaxel hypersensitivity reactions","volume":"6","author":"Otani","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B53","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.anai.2015.07.017","article-title":"Risk-stratification protocol for carboplatin and oxaliplatin hypersensitivity: repeat skin testing to identify drug allergy","volume":"115","author":"Wang","year":"2015","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Allergy and Asthma Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/ocean\/aap\/2021\/00000042\/00000001\/art00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T01:54:10Z","timestamp":1697507650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.2500\/aap.2021.42.200091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1,1]]}},"alternative-id":["1088-5412(20210101)42:1L.16;1-"],"URL":"https:\/\/doi.org\/10.2500\/aap.2021.42.200091","relation":{},"ISSN":["1088-5412"],"issn-type":[{"value":"1088-5412","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,1]]}}}